Annals On Call - Diuretic Resistance
Authors: Robert M. Centor, Joel M. Topf
Journal: Annals of Internal Medicine (2018)

Web Exclusives16 October 2018Annals On Call - Diuretic ResistanceFREERobert M. Centor, MD, Joel M. Topf, MDRobert M. Centor, MDHuntsville Regional Medical Campus, University of Alabama Birmingham School of Medicine, Birmingham, Alabama (R.M.C.)Search for more papers by this author, Joel M. Topf, MDOakland University William Beaumont School of Medicine, Rochester, Michigan (J.M.T.)Search for more papers by this authorAuthor, Article and Disclosure Informationhttps://doi.org/10.7326/A18-0006 CME/MOC SectionsAboutVisual Abstract ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail In this episode of Annals On Call, Dr. Centor discusses diuretic resistance in patients with heart failure with Dr. Joel Topf. Listeners will gain knowledge to help make better-informed choices when prescribing diuretics to patients with heart failure.Annals articles discussed include...The Physiologic Basis of Diuretic Synergism: Its Role in Treating Diuretic Resistance: http://annals.org/aim/fullarticle/704671/physiologic-basis-diuretic-synergism-its-role-treating-diuretic-resistanceAbout Annals On CallAnnals On Call focuses on a clinically influential article published in Annals of Internal Medicine. Dr. Robert Centor shares his own perspective on the material and interviews topic area experts to discuss, debate, and share diverse insights about patient care and health care delivery.For more information on Annals On Call and for more episodes, visit go.annals.org/OnCall. Comments0 CommentsSign In to Submit A Comment Author, Article and Disclosure InformationDisclosures: Dr. Centor has disclosed the following: Honoraria: Medscape. Dr. Topf has disclosed the following: Consultantship: Davita; Other: Davita (joint venture; small ownership of multiple dialysis units and a vascular access center).Editors' Disclosures: Christine Laine, MD, MPH, Editor in Chief, reports that her spouse has stock options/holdings with Targeted Diagnostics and Therapeutics. Darren B. Taichman, MD, PhD, Executive Editor, reports that he has no financial relationships or interests to disclose. Cynthia D. Mulrow, MD, MSc, Senior Deputy Editor, reports that she has no relationships or interests to disclose. Deborah Cotton, MD, MPH, Deputy Editor, reports that she has no financial relationships or interest to disclose. Jaya K. Rao, MD, MHS, Deputy Editor, reports that she has stock holdings/options in Eli Lilly and Pfizer. Sankey V. Williams, MD, Deputy Editor, reports that he has no financial relationships or interests to disclose. Catharine B. Stack, PhD, MS, Deputy Editor for Statistics, reports that she has stock holdings in Proctor & Gamble, Pfizer, and Johnson & Johnson. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited ByThe Gout WarsBurton Abrams, MS 16 October 2018Volume 169, Issue 8Page: OC1KeywordsDiagnostic techniquesMedical dialysisDisclosureHealth careHeart failurePatientsDiuretics ePublished: 16 October 2018 Issue Published: 16 October 2018 CopyrightCopyright © 2018 by American College of Physicians. All Rights Reserved.Loading ...